Landscapes / Targets

IL-2

20 drugs act on IL-2, in 41 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs20

DrugHow it worksCompanyStageNext dateDetails
PD-1/IL-2 bispecific fusion protein
Innovent +1 · Public 1801.HK
Phase 3 30 Nov 2026soonPhase 2 trial completes
—
Phase 3 May 2028Phase 3 trial completes
—
Phase 1/2 28 Feb 2027Phase 1/2 trial completes
—
Phase 1/2 Feb 2027Phase 1/2 trial completes
—
Phase 1/2 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 Aug 2027Phase 1/2 trial completes
—
Regeneron · Public REGN
Phase 2 30 Jun 2028Phase 2 trial completes
—
Phase 1/2 20 Oct 2028Phase 1/2 trial completes
—
Phase 1/2 Jan 2029Phase 1/2 trial completes
—
Phase 2 31 Mar 2029Phase 1/2 trial completes
—
AstraZeneca · Public AZN
Phase 1/2 2 Oct 2029Phase 1/2 trial completes
—
Phase 2 31 Dec 2030Phase 2 trial completes
—
Phase 1/2 Jun 2032Phase 1/2 trial completes
—
Phase 1 Mar 2027Phase 1 trial completes
—
Phase 1 16 Jul 2027Phase 1 trial completes
—
Phase 1 Apr 2028Phase 1 trial completes
—
Phase 1 Jan 2029Phase 1 trial completes
—
Phase 1 26 May 2029Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —

About this list

Checked
20 of 20 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow IL-2

Following is part of Solo: you see every change to IL-2 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in